Characteristics and predictors of long-term institutionalization in patients with schizophrenia

Frequency and correlates of antipsychotic polypharmacy among patients with schizophrenia in Denmark: A nation-wide pharmacoepidemiological study

“…These figures are higher compared to the 19.6% worldwide mean for the 2000-2009 period found in a previous study (Gallego et al, 2012a). The reason for this relatively high prevalence of APP is multifactorial and differences in the organization of the health care system are likely contributing factors (Uggerby et al, 2011). In Denmark, full reimbursement of medication costs is offered to all citizens after a reasonable cost for the patient.…”

The new asylums in the community: severely ill psychiatric patients living in psychiatric supported housing facilities. A Danish register-based study of prognostic factors, use of psychiatric services, and mortality

“…Uggerby et al [15] recently conducted a study of institutionalized patients with schizophrenia and concluded that institutionalized patients died at a higher age than noninstitutionalized patients. However, since the authors did not match the two groups for age at the time of inclusion in the study, this conclusion is most likely not valid.…”

Long-term hospitalizations for schizophrenia in the Czech Republic 1998–2012

“…This might explain excessively long average length of inpatient treatment for schizophrenia, schizotypal and delusional disorders, which was as high as 103 days in 2006 and 115 days in 2012 (IHIS, 2007;IHIS, 2013). In Denmark 2006, only 9.8 % of lifetime schizophrenia patients were institutionalized and their mean number of bed days for that year was 24.9 days (Uggerby et al, 2011). In Zurich canton 2004, median length of inpatient hospitalization for schizophrenia, schizotypal and delusional disorders was 24 days (Lay et al, 2007).…”